STOCK TITAN

MAXIMUS (MMS) Stock News, Jul 2022-Feb 2023

MMS NYSE

Maximus, Inc. reports developments tied to its role as a provider of tech-enabled government services for public programs. The company supports government agencies with business process management, technology solutions, health insurance eligibility and enrollment programs, clinical services, assessments, appeals and independent medical reviews across U.S. Federal Services, U.S. Services and international operations.

Recurring news includes fiscal results, guidance updates, sales-pipeline commentary, segment trends, clinical program demand and productivity initiatives. Company updates also cover AI-enabled tools such as Accuracy Assistant for state SNAP programs, quarterly cash dividends, common-stock repurchase authorizations and governance changes involving senior legal and corporate-secretary roles.

Rhea-AI Summary

Maximus (MMS) reported Q1 FY2023 financial results, with revenue increasing 8.5% to $1.25 billion and organic growth at 10.3%. Diluted EPS was $0.65, with adjusted EPS at $0.94. Due to the scheduled restart of Medicaid redeterminations, the company raised its FY23 revenue guidance to $4.85-$5.0 billion and adjusted EPS guidance to $4.00-$4.30. U.S. Services revenue rose 13.7% to $439.5 million, while the operating margin decreased to 8.6%. The cash dividend of $0.28 per share will be paid on February 28, 2023. Maximus remains focused on capturing growth in government services amid a recovery from pandemic-related challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.30%
Tags
-
Rhea-AI Summary

Maximus (NYSE: MMS) has declared a quarterly cash dividend of $0.28 per share, scheduled for payment on February 28, 2023. Shareholders of record on February 15, 2023 will receive this dividend. As a prominent provider of government services globally, Maximus aims to enhance public service delivery through innovative business process management and technology solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
dividends
-
Rhea-AI Summary

Maximus (NYSE: MMS) will release its financial results for the three months ended December 31, 2022, after market close on February 8, 2023. A conference call will follow on February 9, 2023, at 9:00 a.m. ET, where shareholders can submit questions via email. The call will be accessible to the public through a webcast and by phone. Maximus is a global leader in government services, focusing on improving public service delivery through innovative solutions and operational excellence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences earnings
Rhea-AI Summary

Maximus (NYSE: MMS) has secured a $100 million contract with the Centers for Disease Control and Prevention (CDC) for one base year plus four option years. The contract aims to enhance the CDC-INFO program, providing vital health information to Americans. Maximus will utilize its technology and operational expertise to improve service delivery, especially post-COVID-19. The company has previously supported the CDC-VAX program during the pandemic, earning multiple awards for its efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.42%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS) announced it will release its financial results for the fiscal year and quarter ending September 30, 2022, after market close on November 21, 2022. A conference call will follow on November 22, 2022, at 9:00 a.m. ET. Shareholders can submit questions for management via email until one hour prior to the call. The event will be accessible to the public through a webcast and by phone.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
conferences earnings
-
Rhea-AI Summary

Maximus (NYSE:MMS) has announced the transition of Dr. Arvenita W. Cherry to the role of President of the Maximus Foundation, effective October 1. She succeeds Dr. John Boyer, who served for 17 years and will remain as Chairman until his retirement later this fiscal year. The Maximus Foundation is dedicated to supporting community and healthcare initiatives, recently distributing $2 million in grants to 167 nonprofits in the U.S. Dr. Cherry aims to align the foundation’s focus with the company’s diversity, equity, and inclusion strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.12%
Tags
none
Rhea-AI Summary

Maximus (NYSE: MMS) has declared a quarterly cash dividend of $0.28 per share, set to be paid on November 30, 2022. Shareholders must be on record by November 15, 2022 to qualify for this dividend. This move highlights Maximus's commitment to returning income to its shareholders, reflecting the company's financial health and operational stability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
dividends
-
Rhea-AI Summary

Maximus (NYSE: MMS) has secured a new contract valued at $6.6 billion from the Centers for Medicare & Medicaid Services (CMS) to support Contact Center Operations. This contract aims to assist 75 million Americans in accessing Medicare and health insurance through the Federal Marketplace initiated by the Affordable Care Act. The contract includes a transition period and nine optional one-year extensions, enhancing Maximus' role in delivering customer service and information about federal healthcare programs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS) reported a revenue decline of $118 million for Q3 FY2022, totaling $1.13 billion, impacted by a $413 million reduction in COVID-19 response work. Despite this, organic growth in the U.S. Federal Services Segment and a pipeline of signed contracts totaling $4.02 billion highlight future growth potential. Diluted EPS stood at $0.51, affected by an $11.7 million write-down. Full-year guidance remains unchanged for revenue at $4.6 billion, while EPS is projected between $2.85 and $3.05. A quarterly dividend of $0.28 per share will be paid on August 31, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.98%
Tags
Rhea-AI Summary

Maximus (NYSE: MMS) will release its financial results for the three and nine months ending June 30, 2022, on August 3, 2022, after market close. A conference call will follow on August 4 at 9:00 a.m. ET. Shareholders can submit questions to management before the call by emailing IR@maximus.com. To listen, participants can join via webcast or phone: 877.407.8289 (Domestic) / +1.201.689.8341 (International). A recording will be available post-call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
conferences earnings

FAQ

What is the current stock price of MAXIMUS (MMS)?

MAXIMUS (MMS) last closed at $65.40.

What is the market cap of MAXIMUS (MMS)?

The market cap of MAXIMUS (MMS) is approximately $3.4B.